Attention deficit hyperactivity disorder, or ADHD, is a developmental disorder that affects approximately 2–5% of adults ...

Half of clinical trials on adult ADHD lack thorough diagnostic assessments, undermining their reliability and treatment ...

Increasing access to ADHD diagnosis and medication is a good move. But it shouldn’t be the whole plan to address a condition ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia. With ...

The average ADHD medication treatment for children exceeds three years while safety data only covers one year. Boys starting ...

Actress and talk show host Busy Philipps as well as sports reporter Jay Glazer have both headed up separate campaigns for Qelbree, a non-stimulant ADHD treatment manufactured by Supernus. This marks a ...

A study finds that kids who are the youngest in their school class are significantly more likely to be diagnosed with mental ...

While the study focused on healthy university students, similar benefits have been observed in children with math learning ...

Children younger than 6 years of age who are prescribed extended-release stimulants for attention-deficit hyperactivity disorder (ADHD) may experience ...

The British Dietic Association (BDA) has highlighted that children need a variety of nutrients to help support their brain ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Research published in the Australian Journal of General Practice (AJGP) has revealed mental health and developmental–behavioural issues such as ADHD ...